Bio X Cell InVivoSIM™
Biosimilar monoclonal antibodies - with 15% discount
Bio X Cell InVivoSIM™ non-therapeutic antibodies are research-grade biosimilar monoclonal antibodies that have the same active biological component as the original therapeutic antibodies. Biosimilars make it possible to study the biological effects of a drug without the need to source an expensive pharmaceutical-grade therapeutic.
Features of Bio X Cell InVivoSIM™ antibodies:
- greater than 95% purity
- free of preservatives, stabilizers, and carrier proteins
- screened for murine pathogens and protein aggregation
- binding validation via immunoblot
- less than 1 endotoxin unit per milligram guaranteed
InVivoSIM™ antibodies are for Research Use Only (RUO) and are not for therapeutic use.
Art. Nr. | Product Name | Applications |
---|---|---|
BXC-SIM0001 | InVivoSIM™ anti-human TNFα (Adalimumab Biosimilar) | TNFα neutralization; FC, ELISA; IF; IP; IHC; WB |
BXC-SIM0002 | InVivoSIM™ anti-human EGFR (Cetuximab Biosimilar) | GFR blockade; ELISA; FC |
BXC-SIM0003 | InVivoSIM™ anti-human PD-1 (Nivolumab Biosimilar) | Blocking of PD-1/PD-L signaling; FC; IHC; WB |
BXC-SIM0004 | InVivoSIM™ anti-human CTLA-4 (Ipilimumab Biosimilar) | CTLA-4 neutralization; FC; ELISA; WB |
BXC-SIM0005 | InVivoSIM™ anti-human HER2 (Trastuzumab Biosimilar) | FC; ELISA; IHC; WB |
BXC-SIM0006 | InVivoSIM™ anti-human TNFα (Infliximab Biosimilar) | TNFα neutralization; FC; ELISA; WB |
BXC-SIM0007 | InVivoSIM™ anti-human VEGF (Bevacizumab Biosimilar) | VEGF neutralization; FC; ELISA; IP |
BXC-SIM0008 | InVivoSIM™ anti-human CD20 (Rituximab Biosimilar) | FC; ELISA; WB |
BXC-SIM0009 | InVivoSIM™ anti-human PD-L1 (Atezolizumab Biosimilar) | FC; WB |
BXC-SIM0010 | InVivoSIM™ anti-human PD-1 (Pembrolizumab Biosimilar) | FA |
BXC-SIM0011 | InVivoSIM™ anti-human C5 (Eculizumab Biosimilar) | FA, ELISA, IP |
BXC-SIM0012 | InVivoSIM™ anti-human VEGFR-2 (Ramucirumab Biosimilar) | FA, IHC, FC |
BXC-SIM0013 | InVivoSIM™ anti-human IL-17A (Secukinumab Biosimilar) | FA, ELISA, IF, IHC, FC |
BXC-SIM0014 | InVivoSIM™ anti-human IL-6R (Tocilizumab Biosimilar) | FA, ELISA |
BXC-SIM0015 | InVivoSIM™ anti-human LAG-3 (Relatlimab Biosimilar) | ELISA |
BXC-SIM0016 | InVivoSIM™ anti-human IgE (Omalizumab Biosimilar) | ELISA, FC |
12.10.2022

GeneTex Webinar
Ovarian cancer formation and spread

March Conferences
Meet BIOZOL in Göttingen, Ulm, and Munich

How to succeed with...
Live Webinar from Mabtech

Human Pluripotent St...
Differentiation Guide from Qkine

BIOZOL acquires Alph...
AlphaScience part of BIOZOL